NCT02434653

Brief Summary

Anemia diagnosis by hemoglobin level monitoring in women after vaginal delivery by symptoms versus screening of women at increased risk for post-partum anemia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,679

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 5, 2015

Completed
27 days until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

July 14, 2017

Status Verified

May 1, 2017

Enrollment Period

1.9 years

First QC Date

April 28, 2015

Last Update Submit

July 12, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • The rate of patients diagnosed with anemia

    Hemoglobin of 10 g/dl or below

    Up to 3 days postpartum

  • The rate of patients who received treatment with intravenous iron sucrose

    Up to 3 days postpartum

Secondary Outcomes (8)

  • The rate of patients who received blood transfusion

    From delivery and up to 5 days

  • The rate of women with post-partum hemorrhage

    From delivery and up to 5 days

  • The rate of women who underwent uterine revision following delivery after their arrival to the maternity ward

    From delivery and up to 5 days

  • The rate of women who needed uterotonic agents after their arrival to the maternity ward

    From delivery and up to 5 days

  • The average blood tests number that was performed

    From delivery and up to 5 days

  • +3 more secondary outcomes

Study Arms (2)

Postpartum anemia diagnosis following symptoms

EXPERIMENTAL

Post partum anemia will be assessed by taking hemoglobin level following symptoms consistent with anemia, severe postpartum hemorrhage or hemoglobin level below 8 g/dL in the first 5 days following delivery

Other: Monitoring hemoglobin levels following anemia associated symptoms

Postpartum anemia diagnosis following patients screening

EXPERIMENTAL

Post partum anemia will be assessed by taking hemoglobin level in patients at increased risk to develop post-partum anemia in the first 5 days following delivery, defined as patients with initial (before or immediately after delivery) hemoglobin level of 10.5 g/dl or less regardless of symptoms, or in cases of severe post partum hemorrhage.

Other: Monitoring hemoglobin levels to detect anemia by screening of women at increased risk for post partum anemia

Interventions

Post-partum anemia will be diagnosed after vaginal delivery by taking hemoglobin levels to patients with symptoms consistent with anemia, severe postpartum hemorrhage or hemoglobin level below 8 g/dL.

Postpartum anemia diagnosis following symptoms

Post-partum anemia will be diagnosed after vaginal delivery by taking hemoglobin levels to high risk women for post-partum anemia, defined as hemoglobin levels of 10.5 g/dl or below around delivery, or severe postpartum hemorrhage with or without symptoms associated with anemia

Postpartum anemia diagnosis following patients screening

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • pregnant women after vaginal delivery

You may not qualify if:

  • pregnant women with known sensitivity to the product iron sucrose
  • pregnant women after cesarean section

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haemek Medical Center

Afula, Israel

Location

Related Publications (1)

  • Yefet E, Yossef A, Nachum Z. Prediction of anemia at delivery. Sci Rep. 2021 Mar 18;11(1):6309. doi: 10.1038/s41598-021-85622-7.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD/PhD

Study Record Dates

First Submitted

April 28, 2015

First Posted

May 5, 2015

Study Start

June 1, 2015

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

July 14, 2017

Record last verified: 2017-05

Locations